Is elevated SUA associated with a worse outcome in young Chinese patients with acute cerebral ischemic stroke?

BMC Neurology

Volumn 10, Issue , 2010, Pages

  Zhang, Bin ^a   Gao, Cong ^a   Yang, Ning ^a   Zhang, WeiZhi ^b   Song, XingWang ^a   Yin, JianRui ^a   Pu, ShuXiang ^a   Yi, YongHong ^a   Gao, QingChun ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

URIC ACID; BIOLOGICAL MARKER;

ACUTE DISEASE; ADULT; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPROTECTION; OCCLUSIVE CEREBROVASCULAR DISEASE; PROGNOSIS; RANKIN SCALE; URIC ACID BLOOD LEVEL; ASIAN; BLOOD; CONVALESCENCE; PHYSIOLOGY; STROKE;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; PROGNOSIS; RECOVERY OF FUNCTION; STROKE; URIC ACID;

EID: 77956576022     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-10-82     Document Type: Article

References (24)

1. Alderman M, Aiyer KJ. Uric acid: role in cardiovascular disease and effects of losartan. Curr Med Res Opin 2004, 20:369-79. 10.1185/030079904125002982, 15025846.
2. Alderman MH. Uric acid and cardiovascular risk. Curr Opin Pharmacol 2002, 2:126-30. 10.1016/S1471-4892(02)00143-1, 11950622.
3. Puig JG, Ruilope LM. Uric acid as a cardiovascular risk factor in arterial hypertension. J Hypertens 1999, 17:869-72. 10.1097/00004872-199917070-00001, 10419058.
4. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality:the NHANES I epidemiologic follow-up study, 1971-1992. JAMA 2000, 283:2404-10. National Health and Nutrition Examination Survey, 10.1001/jama.283.18.2404, 10815083.
5. Hozawa A, Folsom AR, Ibrahim H, Javier Nieto F, Rosamond WD, Shahar E. Serum uric acid and risk of ischemic stroke: the ARIC Study. Atherosclerosis 2006, 187:401-7. 10.1016/j.atherosclerosis.2005.09.020, 16239005.
6. Lehto S, Niskanen L, Ronnemaa T, Laakso M. Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke 1998, 29:635-9.
7. Weir CJ, Muir SW, Walters MR, Lees KR. Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke. Stroke 2003, 34:1951-6. 10.1161/01.STR.0000081983.34771.D2, 12843346.
8. Hink HU, Santanam N, Dikalov S, McCann L, Nguyen AD, Parthasarathy S, Harrison DG, Fukai T. Peroxidase properties of extracellular superoxide dismutase: role of uric acid in modulating in vivo activity. Arterioscler Thromb Vasc Biol 2002, 22:1402-8. 10.1161/01.ATV.0000027524.86752.02, 12231557.
9. Love S. Oxidative stress in brain ischaemia. Brain Pathol 1999, 9:119-31. 10.1111/j.1750-3639.1999.tb00214.x, 9989455.
10. Uemura Y, Miller JM, Matson WR, Beal MF. Neurochemical analysis of focal ischemia in rats. Stroke 1991, 22:1548-53.
11. Hink HU, Santanam N, Dikalov S, McCann L, Nguyen AD, Parthasarathy S, Harrison DG, Fukai T. Peroxidase Properties of Extracellular Superoxide Dismutase Role of Uric Acid in Modulating In Vivo Activity. Arterioscler Thromb Vasc Biol 2002, 22:1402-8. 10.1161/01.ATV.0000027524.86752.02, 12231557.
12. Chamorro A, Obach V, Cervera A, Revilla M, Deulofeu R, Aponte JH. Prognostic significance of uric acid serum concentration in patients with acute ischemic stroke. Stroke 2002, 33:1048-52. 10.1161/hs0402.105927, 11935059.
13. Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. TOAST: Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993, 24:35-41.
14. O'Malley T, Langhorne P, Elton RA, Stewart C. Platelet size in strokepatients. Stroke 1995, 26:995-9.
15. Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G. Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417 734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS). J Intern Med 2009, 266:558-70. 10.1111/j.1365-2796.2009.02133.x, 19563390.
16. Niskanen LK, Laaksonen DE, Nyyssonen K, Alfthan G, Lakka HM, Lakka TA, Salonen JT. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med 2004, 164:1546-51. 10.1001/archinte.164.14.1546, 15277287.
17. Ward HJ. Uric acid as an independent risk factor in the treatment of hypertension. Lancet 1998, 352:670-1. 10.1016/S0140-6736(05)60816-1, 9728978.
18. Wannamethee SG, Shaper AG, Whincup PH. Serum urate and the risk of major coronary heart disease events. Heart 1997, 78:147-53. 484894, 9326988.
19. Alderman MH, Cohen H, Madhavan S, Kivlighn S. Serum uric acid and cardiovascular events in successfully treated hypertensive patients. Hypertension 1999, 34:144-50.
20. Leinonen JS, Ahonen JP, Loennrot K, Jehkonen M, Dastidar P, Molnr G, et al. Plasma antioxidant capacity is associated with high lesion volume and neurological impairment in stroke. Stroke 2000, 31:33-9.
21. Waring WS, Webb DJ, Maxwell RJ. Systemic uric acid administration increases serum antioxidant capacity in healthy volunteers. J Cardiovasc Pharmacol 2001, 38:365-71. 10.1097/00005344-200109000-00005, 11486241.
22. Yu ZF, Bruce-Keller AJ, Goodman Y, Mattson MP. Uric acid protects neurons against excitotoxic and metabolic insults in cell culture, and against focal ischemic brain injury in vivo. J Neurosci Res 1998, 53:613-25. 10.1002/(SICI)1097-4547(19980901)53:5<613::AID-JNR11>3.0.CO;2-1, 9726432.
23. Nieto FJ, Iribarren C, Gross MD, Comstock GW, Cutler RG. Uric acid and serum antioxidant capacity: a reaction to atherosclerosis?. Atherosclerosis 2000, 148:131-9. 10.1016/S0021-9150(99)00214-2, 10580179.
24. Waring WS, Convery A, Mishra V, Shenkin A, Webb DJ, Maxwell SRJ. Uric acid reduces exercise-induced oxidative stress in healthy adults. Clinical Science 2003, 105:425-30. 10.1042/CS20030149, 12801243.